Literature DB >> 30460901

Metastatic small bowel occlusion as initial presentation of squamous cell carcinoma of the lung.

Rita Seara Costa1, Ana Luisa Vieira2, Juliana M Costa1, Beatriz Fernandes2, Anibal Ferreira1.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 30460901      PMCID: PMC6505651          DOI: 10.5152/tjg.2018.18419

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


× No keyword cloud information.
  5 in total

1.  Gastro-intestinal metastasis of primary lung carcinoma: clinical presentations and outcome.

Authors:  Chih-Jen Yang; Jhi-Jhu Hwang; Wang-Yi Kang; Inn-Wen Chong; Tung-Heng Wang; Chau-Chyun Sheu; Jong-Rung Tsai; Ming-Shyan Huang
Journal:  Lung Cancer       Date:  2006-09-27       Impact factor: 5.705

2.  Small bowel metastases from primary carcinoma of the lung.

Authors:  P M McNeill; L D Wagman; J P Neifeld
Journal:  Cancer       Date:  1987-04-15       Impact factor: 6.860

3.  Analysis of gastrointestinal metastasis of primary lung cancer: Clinical characteristics and prognosis.

Authors:  Naohiro Taira; Tsutomu Kawabata; Atsushi Gabe; Tomonori Furugen; Takaharu Ichi; Kazuaki Kushi; Tomofumi Yohena; Hidenori Kawasaki; Daisuke Higuchi; Kenji Chibana; Kaori Fujita; Atsushi Nakamoto; Isoko Owan; Mutsuo Kuba; Kiyoshi Ishikawa
Journal:  Oncol Lett       Date:  2017-06-14       Impact factor: 2.967

4.  Small bowel metastases from primary carcinoma of the lung: clinical findings and outcome.

Authors:  A Berger; C Cellier; C Daniel; C Kron; M Riquet; J P Barbier; P H Cugnenc; B Landi
Journal:  Am J Gastroenterol       Date:  1999-07       Impact factor: 10.864

5.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.